GBT Short Information, Global Blood Therapeutics Inc.

Twenty Trading Day Totals
Total Shorted Volume	5,131,779
Total Actual Volume	29,706,294

Averages
Average Short Volume	256,589
Average Short Percentage	37.82%

Is there a GBT Short Squeeze or Breakout about to happen?

See the GBT Short Analysis for free Sign up or Login

Stock Date	Open Price	Close Price	High	Low	Total Volume	Short Volume	Short Percentage
2022-06-23	28.86	30.93	30.945	28.785	1,975,154	181,624	24.8925
2022-06-22	27.92	28.74	29.96	27.89	1,716,812	226,113	31.9070
2022-06-21	26.82	28.58	29.39	26.79	3,344,267	1,374,667	74.5178
2022-06-16	22.57	23.81	24.14	22.34	1,698,494	425,116	64.4721
2022-06-15	22.53	23.17	23.558	22.39	1,851,405	266,445	31.1656
2022-06-14	22.86	22.3	22.95	22.01	1,343,616	132,351	21.6696
2022-06-13	22.37	22.54	22.96	21.65	1,694,270	267,835	39.0110
2022-06-09	24	23.02	24.51	22.96	1,490,907	86,378	17.4728
2022-06-08	24.13	24.42	25.005	24	1,363,195	81,597	15.6743
2022-06-06	26.42	24.29	26.57	23.24	1,887,696	206,445	21.1639
2022-06-03	24.82	26.11	26.39	24.765	1,588,267	214,970	27.0643
2022-06-02	24.05	25.01	25.25	23.35	1,086,349	96,616	25.0190
2022-06-01	24.97	24.02	25.3317	23.31	1,297,074	376,472	63.7224
2022-05-31	25.97	24.94	26.165	24.34	1,624,547	246,828	48.3856
2022-05-26	25.24	25.46	26.16	25.0768	680,602	83,304	28.4910
2022-05-25	25.59	25.23	25.97	24.5	1,154,777	226,577	40.3026
2022-05-24	26.44	25.68	26.62	25.39	832,420	124,527	38.3450
2022-05-23	27.77	26.77	27.81	26.6095	885,063	162,281	36.4526
2022-05-19	26.98	26.84	27.65	25.85	1,258,934	209,531	50.4678
2022-05-18	27.81	27.04	28.41	26.65	932,445	142,102	56.2584

Stock Information

Global Blood Therapeutics Inc. Company Name:

GBT Stock Symbol:

NASDAQ Market:

Get GBT Alerts

News, Short Squeeze, Breakout and More Instantly...

GBT - NFL Running Back Tevin Coleman and Family Team Up with GBT to Share Playbook for Families Affected by Sickle Cell Disease

SOUTH SAN FRANCISCO, Calif., June 16, 2022 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced a new partnership with New York Jets running back Tevin Coleman and his wife, Akilah, whose 4-year-old daughter lives with sickle cell disease (SCD), with ...
GBT - New GBT Multinational Survey Shines a Needed Light on the Misunderstood Realities, Unseen Burden and Care Challenges of Sickle Cell Disease

SOUTH SAN FRANCISCO, Calif., June 13, 2022 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced results from the S ickle Cell H ealth A wareness, P erspectives and E xperiences (SHAPE) survey, a multinational survey on the burden o...
GBT - GBT Presents Positive New Real-World Evidence Data at EHA2022 Congress Further Supporting Clinical Use of Oxbryta® (voxelotor) in Sickle Cell Disease

Positive results from Phase 1 study of GBT601, including incremental new data, support advancing into planned Phase 2/3 trial by mid-year GBT to hold investor conference call and webcast today at 3:00 p.m. CEST (9:00 a.m. EDT) to highlight EHA data and provide business updates ...